| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/24/2013 | CN101190206B Orally-administered solid composition capable of reducing irritation of digestion tube |
| 04/24/2013 | CN101072551B Sustained release formulation comprising bisphosphonate |
| 04/23/2013 | US8428712 Concurrent delivery of treatment therapy with telemetry in an implantable medical device |
| 04/23/2013 | US8426556 Method of producing FR901228 |
| 04/23/2013 | US8426492 Oxidized cationic polysaccharide-based polymer tissue adhesive for medical use |
| 04/23/2013 | US8426474 Antimicrobial wash and carrier solutions and uses thereof |
| 04/23/2013 | US8426472 Method and composition for administering an NMDA receptor antagonist to a subject |
| 04/23/2013 | US8426463 [((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy |
| 04/23/2013 | US8426399 Methods of treating hypertriglyceridemia |
| 04/23/2013 | US8426391 Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 |
| 04/23/2013 | US8425996 Indicators for detecting the presence of metabolic byproducts from microorganisms |
| 04/23/2013 | US8425980 Method of delivering compositions to substrates |
| 04/23/2013 | US8425940 Agent-encapsulating micro-and nanoparticles, methods for preparation of same and products containing same |
| 04/23/2013 | US8425939 Remedy |
| 04/23/2013 | US8425938 Pharmaceutical composition |
| 04/23/2013 | US8425937 Pharmaceutical compositions for glucocorticoid replacement therapy |
| 04/23/2013 | US8425936 Antibiotic product, use and formulation thereof |
| 04/23/2013 | US8425935 Pharmaceutical formulation for producing rapidly disintegrating tablets |
| 04/23/2013 | US8425934 Using 3-(7-(2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-1,2,3triazolo(4,5)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane( 1 ,2-diol |
| 04/23/2013 | US8425933 Abuse-resistant oral dosage forms and method of use thereof |
| 04/23/2013 | US8425932 Delivery system for remote treatment of an animal |
| 04/23/2013 | US8425931 Biodegradable hyaluronic acid derivative |
| 04/23/2013 | US8425929 Sustained release intraocular implants and methods for preventing retinal dysfunction |
| 04/23/2013 | US8425892 Extended, controlled-release pharmaceutical compositions using charged polymers |
| 04/23/2013 | US8425879 Metalloporphyrin derivatives, nanoparticles comprising the same, and use thereof for photodynamic therapy |
| 04/23/2013 | US8425493 Implantable medication delivery device |
| 04/23/2013 | US8425492 In vivo device, system and usage thereof |
| 04/23/2013 | US8425477 Method and system for providing targeted and individualized delivery of cosmetic actives |
| 04/23/2013 | US8425457 Devices, systems and methods for diagnosing and treating sinusitus and other disorder of the ears, nose and/or throat |
| 04/23/2013 | CA2696984C Improved pharmaceutical composition containing a selective estrogen receptor modulator and method for the preparation thereof |
| 04/23/2013 | CA2666322C Aqueous systems for the preparation of lipid-based pharmaceutical compounds; compositions, methods, and uses thereof |
| 04/23/2013 | CA2599697C Chemically defined stabiliser composition |
| 04/23/2013 | CA2581999C Preparation of suspension aerosol formulations |
| 04/23/2013 | CA2581125C Modified poly(ethylene oxide-amino acid) copolymer, micelle preparation, and anticancer agent containing the same |
| 04/23/2013 | CA2552311C Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity |
| 04/23/2013 | CA2516331C Combination therapy using glycosaminoglycans and therapeutic agents for the treatment of respiratory disorders |
| 04/23/2013 | CA2493514C Compositions for removing stains from dental surfaces, and methods of making and using the same |
| 04/23/2013 | CA2493081C Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 04/23/2013 | CA2475102C Stabilized synthetic immunogen delivery systems |
| 04/23/2013 | CA2458394C Lipophilic drug compositions |
| 04/23/2013 | CA2410563C Methods for preventing strokes by inducing tolerance to e-selectin |
| 04/23/2013 | CA2377517C Amphiphilic drug-oligomer conjugates with hydrolyzable lipophile components and methods for making and using the same |
| 04/18/2013 | WO2013056246A1 Buffered oxygen therapeutic |
| 04/18/2013 | WO2013056213A1 Ingestible multi-sheet unit having predetermined functions and combinations |
| 04/18/2013 | WO2013056197A1 Degradation resistant hsp70 formulations and uses thereof |
| 04/18/2013 | WO2013056170A1 In situ forming hydrogel and method using same |
| 04/18/2013 | WO2013056167A1 Water-stable hydrogel and method using same |
| 04/18/2013 | WO2013056159A1 Methods and compositions for rapid transbuccal delivery of active agents |
| 04/18/2013 | WO2013056132A2 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof |
| 04/18/2013 | WO2013056108A2 Solid dispersion |
| 04/18/2013 | WO2013056092A1 Multi-component nanochains |
| 04/18/2013 | WO2013056088A1 Dietary supplements with rapid buccal dissolution |
| 04/18/2013 | WO2013056048A2 Nutritional products comprising beta-alanine |
| 04/18/2013 | WO2013055990A1 Pyrrolobenzodiazepines and targeted conjugates |
| 04/18/2013 | WO2013055920A1 Methods and compositions for treating parasitic worm infections in a mammal |
| 04/18/2013 | WO2013055889A2 Implantable scaffolds and methods of use |
| 04/18/2013 | WO2013055856A1 Ocular composition containing bromfenac with increased bioavailability |
| 04/18/2013 | WO2013055791A1 Polymeric nanoparticles for ultrasound imaging and therapy |
| 04/18/2013 | WO2013055687A2 R(+)-n-formyl-propargyl-aminoindan |
| 04/18/2013 | WO2013055668A1 Injection-molded dosage form |
| 04/18/2013 | WO2013055540A1 Non-chemotherapeutic antibiotic treatment for infections in cattle |
| 04/18/2013 | WO2013055302A1 Effervescent composition comprising n- acetylcysteine and doxophylline or theophylline |
| 04/18/2013 | WO2013055245A1 Prevention and reduction of uncontrolled decrease of blood glucose levels in diabetic patients |
| 04/18/2013 | WO2013055177A1 Composite formulation comprising a tablet encapsulated in a hard capsule |
| 04/18/2013 | WO2013055073A2 Ophthalmic composition containing cyclosporine and method for preparing same |
| 04/18/2013 | WO2013055058A2 Antibody-binding peptide-ferritin fusion protein and uses thereof |
| 04/18/2013 | WO2013055041A1 Emulsified hydrogel composition and a production method therefor |
| 04/18/2013 | WO2013054872A1 TABLET INCLUDING 7-[4-(4-BENZO[ｂ]THIOPHEN-4-YL-PIPERAZIN-1-YL) BUTOXY]-1H-QUINOLIN-2-ONE OR SALT THEREOF |
| 04/18/2013 | WO2013054809A1 External preparation for skin |
| 04/18/2013 | WO2013054582A1 Orally dispersible tablet |
| 04/18/2013 | WO2013054352A1 Pharmaceutical compositions of ibuprofen and famotidine |
| 04/18/2013 | WO2013054337A1 Extended release pharmaceutical compositions of fesoterodine |
| 04/18/2013 | WO2013054330A1 Foam formulations |
| 04/18/2013 | WO2013054304A1 Use of an oral composition including a mixture of a least one polyphenol, zinc, and vitamin c |
| 04/18/2013 | WO2013054298A2 Modified polyethylene glycols and their supramolecular complexes with biologically active macromolecules |
| 04/18/2013 | WO2013054285A1 A gastroretentive dosage system and process of preparation thereof |
| 04/18/2013 | WO2013054178A2 Extended release pharmaceutical compositions containing carmabazepine |
| 04/18/2013 | WO2013054137A1 Compositions comprising salbutamol sulphate |
| 04/18/2013 | WO2013054135A1 Compositions comprising salbutamol sulphate |
| 04/18/2013 | WO2013053856A1 Prevention and treatment of ocular conditions |
| 04/18/2013 | WO2013053793A1 Novel coating system |
| 04/18/2013 | WO2013053696A1 Crystalline microparticles of a beta-agonist coated with a fatty acid |
| 04/18/2013 | WO2013053485A1 Formulations containing quetiapine |
| 04/18/2013 | WO2013053042A1 Porphyrin-phospholipid conjugate microbubbles and their use as contrast agents. |
| 04/18/2013 | WO2013022991A3 Methods and compositions relating to p62 for the treatment and prophylaxis of cancer |
| 04/18/2013 | WO2013006761A3 Pyrroloquinolinyl-pyrrolidine-2,5-dione formulations and methods for preparing and using same |
| 04/18/2013 | WO2013006683A3 Bio-mimetic ultrathin hydrogel coatings for pancreatic islet transplantation |
| 04/18/2013 | WO2012158030A3 Drug delivery system |
| 04/18/2013 | WO2012145491A3 Composition and method for enhancing an immune response |
| 04/18/2013 | WO2012094302A3 Drug delivery using fine fiber encapsulation |
| 04/18/2013 | WO2012003349A3 Dissolvable fibrous web structure article comprising active agents |
| 04/18/2013 | US20130096496 Long term drug delivery devices with polyurethane based polymers and their manufacture |
| 04/18/2013 | US20130096198 Tranexamic Acid Formulations |
| 04/18/2013 | US20130096196 Pharmaceutical semi-solid composition of isotretinoin |
| 04/18/2013 | US20130096123 Radiation sensitiser compositions |
| 04/18/2013 | US20130096097 Pharmaceutical multimeric particles, and manufacturing method for same |
| 04/18/2013 | US20130096091 Composition for preventing or treating osteoporosis, and manufacturing method therefor |
| 04/18/2013 | US20130096069 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 04/18/2013 | US20130096053 Posaconazole intravenous solution formulations stabilized by substituted beta-cyclodextrin |
| 04/18/2013 | US20130095229 Method of forming dextran and thrombin sheets |